dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema (clinicaltrials.gov) - Dec 2, 2021 - P2/3; N=482; Recruiting; Sponsor: Oculis; Not yet recruiting ➔ Recruiting 
Clinical • Enrollment open • Diabetic Macular Edema • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT05066997
 
Dec 2, 2021
 
Prev Next